Business Wire (May 9, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,004 people get BCRX articles and Market Currents by email alert.
Get email alerts on BCRX »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 7, 2013)
-
-
-
Business Wire (Apr 23, 2013)
-
-
Business Wire (Apr 16, 2013)
-
-
-
-
-
Business Wire (Apr 1, 2013)
-
Business Wire (Mar 25, 2013)
-
-
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 5, 2013)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
BioCryst Drug Receives Recommendation for Pediatric Approval in JapanMichael Murphy • Mon, Sep 27, 2010 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Best And Worst Of Earnings SeasonBespoke Investment Group • Fri, Nov 16, 2012 -
Today's Market News To Trade On: 5 Stocks Moving On NewsMatthew Smith • Fri, Nov 9, 2012
-
-
-
-
What Moves Biotech Stocks? Ed Arce Has AnswersLife Sciences Report • Thu, Oct 18, 2012 -
-
-
-
-
BioCryst Pharmaceuticals, Inc. Q1 2010 Earnings Call TranscriptWed, Apr 28, 2010
-
BioCryst Pharmaceuticals, Inc. Q4 2009 Earnings Call TranscriptThu, Feb 4, 2010
-
BioCryst Pharmaceuticals, Inc. Q4 2007 Earnings Call TranscriptMon, Mar 24, 2008
-
Business Wire (May 9, 2013)
-
Business Wire (May 7, 2013)
-
Business Wire (Apr 23, 2013)
-
Business Wire (Apr 16, 2013)
-
at MarketWatch.com (Apr 8, 2013)
-
at MarketWatch.com (Apr 8, 2013)
-
Business Wire (Apr 1, 2013)
-
Business Wire (Mar 25, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Jan 2, 2013)
-
Business Wire (Dec 7, 2012)
-
Business Wire (Nov 30, 2012)
-
Business Wire (Nov 12, 2012)
-
at MarketWatch.com (Nov 8, 2012)
-
Business Wire (Nov 8, 2012)
-
Business Wire (Nov 7, 2012)
-
Business Wire (Nov 1, 2012)
-
Business Wire (Oct 30, 2012)
-
Business Wire (Oct 18, 2012)
BCRX vs. ETF Alternatives
Company Description
BioCryst Pharmaceuticals, Inc. is a biotechnology company that designs, optimizes and develops novel drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases. BioCryst integrates the disciplines of biology, crystallography, medicinal chemistry and computer... More
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
freefdawatchlist
http://stks.co/jE5o Stocks for Nov 1st: $CRUS, $ZUMZ, $ELLI, $BCRX, $OTEX http://stks.co/fEE2 - View all 0 replies
-
Michael Clark
BUY: PCLN, TXT, BCRX, JDSU. VIX. SHORT: SCHN, XOMA, CORT, AOBI. Momentum still down in markets. http://seekingalpha.com/p/j7sh - View all 5 replies
-
Michael Clark: He's a clown. Actually the markets move up and down like a breathing process. The talking head say this caused that and that caused this.
-
Michael Clark: In truth, the market breathed out; and will soon again breathe in. European system isn't fixed. They've said their in charge before.
-
Roy Manning III
BCRX has sold off alot. I would consider it a buy now. News on a Gout drug partner or their Hep C. patent could push the stock higher. - View all 0 replies
-
- View all 0 replies
-
- View all 1 replies
-
LATEST REPLIES
-
Michael Clark
BUY: PCLN, TXT, BCRX, JDSU. VIX. SHORT: SCHN, XOMA, CORT, AOBI. Momentum still down in markets. http://seekingalpha.com/p/j7sh - View all 5 replies
-
Michael Clark: He's a clown. Actually the markets move up and down like a breathing process. The talking head say this caused that and that caused this.
-
Michael Clark: In truth, the market breathed out; and will soon again breathe in. European system isn't fixed. They've said their in charge before.
-
- View all 1 replies
-
-
- View all 1 replies
-